(1)
Chen, S. L.; Feng, Y.; Xue, J.; Wang, S.; Wu, S. L. Efficacy and Safety of Orelabrutinib for Previously Treated Marginal Zone Lymphoma. J Hematol 2025, 14 (6), 297-306. https://doi.org/10.14740/jh2149.